Tag Archives: Jingwu

Neuroscience at GSK: A Tipping Point?

GSK’s formerly vaunted and successful neuroscience programming has been under siege in recent years, with the Company exiting completely from psychiatry, and upper-level support for neurology appearing shaky at best. Now, we fear that GSK may have reached a ‘tipping … Continue reading

Posted in Big Pharma, BioFollies, Science | Tagged , | Leave a comment